{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T16:33:00Z","timestamp":1789403580158,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011025","name":"Government of Western Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007912","name":"Australian Government Department of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.numecd.2025.104286","type":"journal-article","created":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T06:28:45Z","timestamp":1756535325000},"page":"104286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The effectiveness of intervention with omega-3 fatty acids, eicosapentaenoic and docosahexenoic acid in peripheral arterial disease: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"36","author":[{"given":"Thi K.","family":"Dao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitesh","family":"Nerlekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Nicholls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3846-1414","authenticated-orcid":false,"given":"Kristen J.","family":"Bubb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.numecd.2025.104286_bib1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/01.ATV.18.2.185","article-title":"Peripheral arterial disease in the elderly: the rotterdam Study","volume":"18","author":"Meijer","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.numecd.2025.104286_bib2","series-title":"Heart, stroke and vascular disease: australian facts","year":"2023"},{"issue":"13","key":"10.1016\/j.numecd.2025.104286_bib3","doi-asserted-by":"crossref","DOI":"10.1161\/01.CIR.0000160581.58633.8B","article-title":"Peripheral arterial disease","volume":"111","author":"Gornik","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2025.104286_bib4","series-title":"Mayo Clinic proceedings","article-title":"Peripheral artery disease: current insight into the disease and its diagnosis and management","author":"Olin","year":"2010"},{"issue":"1","key":"10.1016\/j.numecd.2025.104286_bib5","first-page":"50","article-title":"Omega-3 intake in patients with coronary artery disease: focus on recent studies","volume":"21","author":"Aalbers","year":"2010","journal-title":"Cardiovascular Journal of Africa"},{"issue":"9289","key":"10.1016\/j.numecd.2025.104286_bib6","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S0140-6736(01)06351-6","article-title":"Peripheral arterial disease","volume":"358","author":"Ouriel","year":"2001","journal-title":"The lancet"},{"issue":"6","key":"10.1016\/j.numecd.2025.104286_bib7","doi-asserted-by":"crossref","first-page":"827","DOI":"10.4239\/wjd.v12.i6.827","article-title":"Diabetes and peripheral artery disease: a review","volume":"12","author":"Soyoye","year":"2021","journal-title":"World J Diabetes"},{"issue":"6","key":"10.1016\/j.numecd.2025.104286_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.jscai.2022.100513","article-title":"Management of peripheral arterial disease: Lifestyle modifications and medical therapies","volume":"1","author":"King","year":"2022","journal-title":"Journal of the Society for Cardiovascular Angiography & Interventions"},{"issue":"9","key":"10.1016\/j.numecd.2025.104286_bib9","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1161\/CIRCRESAHA.116.303504","article-title":"Surgical intervention for peripheral arterial disease","volume":"116","author":"Vartanian","year":"2015","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.numecd.2025.104286_bib10","first-page":"441","article-title":"Omega-3 fatty acids and cardiovascular disease","volume":"19","author":"Jain","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2","key":"10.1016\/j.numecd.2025.104286_bib12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/01.ATV.0000057393.97337.AE","article-title":"Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association","volume":"23","author":"Kris-Etherton","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.numecd.2025.104286_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2261-14-70","article-title":"The impact of omega-3 polyunsaturated fatty acid supplementation on the incidence of cardiovascular events and complications in peripheral arterial disease: a systematic review and meta-analysis","volume":"14","author":"Enns","year":"2014","journal-title":"BMC Cardiovasc Disord"},{"issue":"7","key":"10.1016\/j.numecd.2025.104286_bib14","article-title":"Omega\u20103 fatty acids for intermittent claudication","author":"Campbell","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.numecd.2025.104286_bib15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.clnu.2021.11.005","article-title":"The impact of nutrition on the development and progression of peripheral artery disease: a systematic review","volume":"41","author":"Adegbola","year":"2022","journal-title":"Clin Nutr"},{"issue":"11","key":"10.1016\/j.numecd.2025.104286_bib16","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1017\/S0007114519000825","article-title":"Postprandial incorporation of EPA and DHA from transgenic Camelina sativa oil into blood lipids is equivalent to that from fish oil in healthy humans","volume":"121","author":"West","year":"2019","journal-title":"Br J Nutr"},{"issue":"1","key":"10.1016\/j.numecd.2025.104286_bib17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.numecd.2025.104286_bib18","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/clc.23055","article-title":"Assessment of omega\u20103 carboxylic acids in statin\u2010treated patients with high levels of triglycerides and low levels of high\u2010density lipoprotein cholesterol: rationale and design of the STRENGTH trial","volume":"41","author":"Nicholls","year":"2018","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.numecd.2025.104286_bib19","first-page":"35","article-title":"Periphery arterialsclerosis","volume":"23","author":"Kuramochi","year":"1991","journal-title":"Gendai Iryo"},{"key":"10.1016\/j.numecd.2025.104286_bib20","series-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Wells","year":"2000"},{"issue":"12","key":"10.1016\/j.numecd.2025.104286_bib21","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines 6. Rating the quality of evidence\u2014imprecision","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"10.1016\/j.numecd.2025.104286_bib22","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jclinepi.2011.03.017","article-title":"GRADE guidelines: 7. Rating the quality of evidence\u2014inconsistency","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.numecd.2025.104286_bib23","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","article-title":"GRADE guidelines: 4. Rating the quality of evidence\u2014study limitations (risk of bias)","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"10.1016\/j.numecd.2025.104286_bib24","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.numecd.2025.104286_bib25","series-title":"The Vascular Society of Great Brtain & Ireland","article-title":"A double-blinded, randomised study to determine the effect of omega-3-marine triglycerides on intermittent claudication","author":"Conway","year":"2005"},{"issue":"6","key":"10.1016\/j.numecd.2025.104286_bib26","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1093\/jn\/135.6.1393","article-title":"Daily supplementation with (n-3) PUFAs, oleic acid, folic acid, and vitamins B-6 and E increases pain-free walking distance and improves risk factors in men with peripheral vascular disease","volume":"135","author":"Carrero","year":"2005","journal-title":"J Nutr"},{"issue":"12","key":"10.1016\/j.numecd.2025.104286_bib27","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.nutres.2006.09.024","article-title":"Simvastatin and supplementation with \u03c9-3 polyunsaturated fatty acids and vitamins improves claudication distance in a randomized PILOT study in patients with peripheral vascular disease","volume":"26","author":"Carrero","year":"2006","journal-title":"Nutr Res (NY)"},{"issue":"5","key":"10.1016\/j.numecd.2025.104286_bib28","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0002-9610(05)81012-8","article-title":"Fish oil supplementation in patients with stable claudication","volume":"160","author":"Gans","year":"1990","journal-title":"Am J Surg"},{"key":"10.1016\/j.numecd.2025.104286_bib29","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jss.2019.01.038","article-title":"Fish oil increases specialized pro-resolving lipid mediators in PAD (the OMEGA-PAD II Trial)","volume":"238","author":"Ramirez","year":"2019","journal-title":"J Surg Res"},{"issue":"6","key":"10.1016\/j.numecd.2025.104286_bib30","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0261-5614(98)80318-X","article-title":"Randomized controlled trial of gamma-linolenic acid and eicosapentaenoic acid in peripheral arterial disease","volume":"17","author":"Leng","year":"1998","journal-title":"Clin Nutr"},{"issue":"2","key":"10.1016\/j.numecd.2025.104286_bib31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.clnu.2007.11.007","article-title":"Omega-3 polyunsaturated fatty acid in peripheral arterial disease: effect on lipid pattern, disease severity, inflammation profile, and endothelial function","volume":"27","author":"Schiano","year":"2008","journal-title":"Clin Nutr"},{"issue":"8","key":"10.1016\/j.numecd.2025.104286_bib32","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002034","article-title":"Short\u2010Term, high\u2010dose fish oil supplementation increases the production of Omega\u20103 Fatty acid\u2013derived mediators in patients with peripheral artery disease (the OMEGA\u2010PAD I trial)","volume":"4","author":"Grenon","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.numecd.2025.104286_bib33","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jss.2016.11.011","article-title":"Predictors of change in omega-3 index with fish oil supplementation in peripheral artery disease","volume":"210","author":"Drudi","year":"2017","journal-title":"J Surg Res"},{"issue":"6","key":"10.1016\/j.numecd.2025.104286_bib34","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1017\/S0007114519001582","article-title":"Effects of n-3 PUFA on endothelial function in patients with peripheral arterial disease: a randomised, placebo-controlled, double-blind trial","volume":"122","author":"Hammer","year":"2019","journal-title":"Br J Nutr"},{"issue":"6417","key":"10.1016\/j.numecd.2025.104286_bib35","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1136\/bmj.288.6417.592","article-title":"Beneficial effect of fish oil on blood viscosity in peripheral vascular disease","volume":"288","author":"Woodcock","year":"1984","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"1","key":"10.1016\/j.numecd.2025.104286_bib36","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1017\/S0007114599001099","article-title":"Olive oil-and fish oil-enriched diets modify plasma lipids and susceptibility of LDL to oxidative modification in free-living male patients with peripheral vascular disease: the Spanish Nutrition Study","volume":"82","author":"Ram\u00edrez-Tortosa","year":"1999","journal-title":"Br J Nutr"},{"issue":"6","key":"10.1016\/j.numecd.2025.104286_bib37","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.plefa.2007.04.003","article-title":"Fish oil induced increase in walking distance, but not ankle brachial pressure index, in peripheral arterial disease is dependent on both body mass index and inflammatory genotype","volume":"76","author":"Madden","year":"2007","journal-title":"Prostagl Leukot Essent Fat Acids"},{"issue":"7","key":"10.1016\/j.numecd.2025.104286_bib38","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1253\/circj.CJ-09-0520","article-title":"Preventive effects of eicosapentaenoic acid on coronary artery disease in patients with peripheral artery disease\u2013subanalysis of the JELIS Trial\u2013","volume":"74","author":"Ishikawa","year":"2010","journal-title":"Circ J"},{"issue":"10","key":"10.1016\/j.numecd.2025.104286_bib39","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/0026-0495(92)90286-J","article-title":"Plasma lipid levels and platelet and neutrophil function in patients with vascular disease following fish oil and olive oil supplementation","volume":"41","author":"Mori","year":"1992","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.numecd.2025.104286_bib40","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.atherosclerosis.2011.12.041","article-title":"Effect of Omega-3 fatty acid supplementation on markers of platelet and endothelial function in patients with peripheral arterial disease","volume":"221","author":"Mackay","year":"2012","journal-title":"Atherosclerosis"},{"issue":"12","key":"10.1016\/j.numecd.2025.104286_bib41","doi-asserted-by":"crossref","first-page":"e673","DOI":"10.1161\/CIR.0000000000000709","article-title":"Omega-3 fatty acids for the management of hypertriglyceridemia: a science advisory from the American Heart Association","volume":"140","author":"Skulas-Ray","year":"2019","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.numecd.2025.104286_bib42","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1510\/icvts.2008.196428","article-title":"Nitric oxide: link between endothelial dysfunction and inflammation in patients with peripheral arterial disease of the lower limbs","volume":"9","author":"de Haro Miralles","year":"2009","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.numecd.2025.104286_bib43","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.biopha.2018.04.118","article-title":"Eicosapentaenoic acid improves endothelial function and nitric oxide bioavailability in a manner that is enhanced in combination with a statin","volume":"103","author":"Mason","year":"2018","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"10.1016\/j.numecd.2025.104286_bib44","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s11883-023-01137-8","article-title":"Effects of Omega-3 fatty acids on flow-mediated dilatation and carotid intima media thickness: a meta-analysis","volume":"25","author":"Lee","year":"2023","journal-title":"Curr Atheroscler Rep"},{"issue":"3","key":"10.1016\/j.numecd.2025.104286_bib45","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jacbts.2024.10.010","article-title":"Emerging pathways of action of eicosapentaenoic acid (EPA)","volume":"10","author":"Bhatt","year":"2025","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.numecd.2025.104286_bib46","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.clnesp.2024.06.053","article-title":"Role of Omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic (DHA) as modulatory and anti-inflammatory agents in noncommunicable diet-related diseases - reports from the last 10 years","volume":"63","author":"Banaszak","year":"2024","journal-title":"Clin Nutr ESPEN"},{"issue":"50","key":"10.1016\/j.numecd.2025.104286_bib47","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000013593","article-title":"Comparison of efficacy and safety of combination therapy with statins and omega-3 fatty acids versus statin monotherapy in patients with dyslipidemia: a systematic review and meta-analysis","volume":"97","author":"Choi","year":"2018","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.numecd.2025.104286_bib48","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jacbts.2024.09.002","article-title":"EPA induces an anti-inflammatory transcriptome in T cells, implicating a triglyceride-independent pathway in cardiovascular risk reduction","volume":"10","author":"Reilly","year":"2025","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.numecd.2025.104286_bib49","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.biomaterials.2018.06.003","article-title":"CD4 T-cells regulate angiogenesis and myogenesis","volume":"178","author":"Kwee","year":"2018","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.numecd.2025.104286_bib50","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3390\/foods12040725","article-title":"Effects of Omega-3 fatty acids supplementation on serum lipid profile and blood pressure in patients with metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials","volume":"12","author":"Liu","year":"2023","journal-title":"Foods"},{"key":"10.1016\/j.numecd.2025.104286_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10408398.2023.2212817","article-title":"Does omega-3 PUFAs supplementation improve metabolic syndrome and related cardiovascular diseases? A systematic review and meta-analysis of randomized controlled trials","author":"Wang","year":"2023","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"6","key":"10.1016\/j.numecd.2025.104286_bib52","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s10741-023-10327-0","article-title":"Does omega-3 supplementation improve the inflammatory profile of patients with heart failure? A systematic review and meta-analysis","volume":"28","author":"Prokopidis","year":"2023","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.numecd.2025.104286_bib53","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.atherosclerosis.2020.08.032","article-title":"Omega-3 fatty acids and risk of cardiovascular disease in Inuit: first prospective cohort study","volume":"312","author":"Senftleber","year":"2020","journal-title":"Atherosclerosis"},{"issue":"9","key":"10.1016\/j.numecd.2025.104286_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107003","article-title":"Importance of Fatty acid compositions in patients with peripheral arterial disease: e107003","volume":"9","author":"Gautam","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.numecd.2025.104286_bib55","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/lipd.12140","article-title":"Peripheral artery disease is associated with a deficiency of Erythrocyte membrane n\u20103 polyunsaturated fatty acids","volume":"54","author":"Ramirez","year":"2019","journal-title":"Lipids"},{"key":"10.1016\/j.numecd.2025.104286_bib56","article-title":"Peripheral artery disease in the lower Extremities\u2014Prevalence and epidemiology","volume":"16","author":"Dasgupta","year":"2018","journal-title":"E-Journal of Cardiology Practice"},{"issue":"Suppl_1","key":"10.1016\/j.numecd.2025.104286_bib57","doi-asserted-by":"crossref","DOI":"10.1161\/circ.144.suppl_1.10627","article-title":"Abstract 10627: benefits of icosapent ethyl in patients with prior peripheral artery disease: reduce-it PAD","volume":"144","author":"Bhatt","year":"2021","journal-title":"Circulation"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475325004405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475325004405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T12:47:39Z","timestamp":1766580459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475325004405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0939475325004405"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2025.104286","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effectiveness of intervention with omega-3 fatty acids, eicosapentaenoic and docosahexenoic acid in peripheral arterial disease: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2025.104286","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University.","name":"copyright","label":"Copyright"}],"article-number":"104286"}}